A consortium known as Program in Innovative Therapeutics for Connecticut’s Health, or PITCH, was established in 2016 to encourage commercialization of research from the state’s universities through the discovery of novel drug compounds. The initiative is supported by a three-year, $10 million investment managed by Connecticut Innovations.

“Programs like PITCH are critical to advancing academic discoveries that will help patients and grow Connecticut’s economy,” says Radenka Maric, vice president for research at UConn and UConn Health. “It also attests to UConn and Yale’s commitment to support cross-disciplinary collaborative research that addresses significant patient needs.”